{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T13:14:10Z","timestamp":1758460450383,"version":"3.44.0"},"reference-count":22,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[1999,4,19]]},"published-print":{"date-parts":[[1999,10,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>To assess the effect of endothelin type A (ET<jats:sub>A<\/jats:sub>) receptor antagonism in infants with pulmonary hypertension following corrective surgery for congenital heart disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>DESIGN<\/jats:title>\n                  <jats:p>Open label, preliminary study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SETTING<\/jats:title>\n                  <jats:p>Tertiary paediatric cardiothoracic surgical centre.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PATIENTS<\/jats:title>\n                  <jats:p>Three infants (aged 3 weeks, 7 weeks, and 8 months) with postoperative pulmonary hypertension unresponsive to conventional treatment, including inhaled nitric oxide.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>INTERVENTIONS<\/jats:title>\n                  <jats:p>Patients received incremental intravenous infusions (0.1 to 0.3 mg\/kg\/h) of the ET<jats:sub>A<\/jats:sub> receptor antagonist BQ-123.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN OUTCOME MEASURES<\/jats:title>\n                  <jats:p>The response to BQ-123 administration was determined using continuous invasive monitoring of cardiorespiratory variables.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>BQ-123 infusion caused a reduction in the ratio of pulmonary to systemic pressures (0.62 (0.01) to 0.52 (0.03), mean (SEM)) with an accompanying decrease in right ventricular stroke work index (4.6 (0.4) to 2.5 (0.3) g\/m) and a tendency for the cardiac index to rise (2.1 (0.2) to 2.7 (0.6) l\/min\/kg\/m<jats:sup>2<\/jats:sup>). This was associated with a well tolerated fall in the arterial partial pressure of oxygen (16.5 (4.1) to 12.4 (3.3) kPa) and mean systemic arterial pressure (57 (3) to 39 (3) mm Hg).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>ET<jats:sub>A<\/jats:sub>receptor antagonism in infants with postoperative pulmonary hypertension after corrective surgery for congenital heart disease led to significant improvement in pulmonary haemodynamic indices. However, these benefits were associated with reductions in systemic blood pressure and arterial oxygen saturation, the latter consistent with a ventilation\u2013perfusion mismatch. On the basis of these results, studies in pulmonary hypertension will need to proceed with caution.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/hrt.82.4.505","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T15:31:45Z","timestamp":1413991905000},"page":"505-508","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Early therapeutic experience with the endothelin antagonist BQ-123 in pulmonary hypertension after congenital heart surgery"],"prefix":"10.1136","volume":"82","author":[{"given":"B","family":"Prendergast","sequence":"first","affiliation":[{"name":"aDepartment of Cardiac Surgery, Royal Hospital for Sick Children, Sciennes Road, Edinburgh EH9 1LF, UK, \n\nbClinical Pharmacology Unit and Research Centre, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D E","family":"Newby","sequence":"additional","affiliation":[{"name":"aDepartment of Cardiac Surgery, Royal Hospital for Sick Children, Sciennes Road, Edinburgh EH9 1LF, UK, \n\nbClinical Pharmacology Unit and Research Centre, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L E","family":"Wilson","sequence":"additional","affiliation":[{"name":"aDepartment of Cardiac Surgery, Royal Hospital for Sick Children, Sciennes Road, Edinburgh EH9 1LF, UK, \n\nbClinical Pharmacology Unit and Research Centre, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D J","family":"Webb","sequence":"additional","affiliation":[{"name":"aDepartment of Cardiac Surgery, Royal Hospital for Sick Children, Sciennes Road, Edinburgh EH9 1LF, UK, \n\nbClinical Pharmacology Unit and Research Centre, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P S","family":"Mankad","sequence":"additional","affiliation":[{"name":"aDepartment of Cardiac Surgery, Royal Hospital for Sick Children, Sciennes Road, Edinburgh EH9 1LF, UK, \n\nbClinical Pharmacology Unit and Research Centre, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1999,10,1]]},"reference":[{"key":"2025092100262408000_82.4.505.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(96)70019-3"},{"key":"2025092100262408000_82.4.505.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(96)00101-5"},{"key":"2025092100262408000_82.4.505.3","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.7.1578"},{"key":"2025092100262408000_82.4.505.4","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.2.359"},{"key":"2025092100262408000_82.4.505.5","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.85.2.504"},{"key":"2025092100262408000_82.4.505.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(96)00189-7"},{"key":"2025092100262408000_82.4.505.7","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/148.2.519"},{"key":"2025092100262408000_82.4.505.8","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-994352"},{"key":"2025092100262408000_82.4.505.9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0022-5223(19)34082-6","article-title":"Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease.","volume":"106","author":"Komai","year":"1993","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025092100262408000_82.4.505.10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00008480-199406000-00003","article-title":"Pathogenesis and treatment of neonatal and postnatal pulmonary hypertension.","volume":"6","author":"Abman","year":"1994","journal-title":"Curr Opin Pediatr"},{"key":"2025092100262408000_82.4.505.11","first-page":"L690","article-title":"ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat.","volume":"269","author":"DiCarlo","year":"1995","journal-title":"Am J Physiol"},{"key":"2025092100262408000_82.4.505.12","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0022-3565(24)36925-3","article-title":"The orally active ETA receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphenyl-proprionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats.","volume":"282","author":"Pri\u00e9","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"2025092100262408000_82.4.505.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6060(05)80356-3"},{"key":"2025092100262408000_82.4.505.14","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.4.1054"},{"key":"2025092100262408000_82.4.505.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92827-4"},{"key":"2025092100262408000_82.4.505.16","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1997.t01-1-00631.x"},{"key":"2025092100262408000_82.4.505.17","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.93.10.1860"},{"key":"2025092100262408000_82.4.505.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803193381202"},{"key":"2025092100262408000_82.4.505.19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(05)77807-7","article-title":"Short term haemodynamic effects of BQ-123, a selective endothelin ET-receptor antagonist, in chronic heart failure.","volume":"352","author":"Cowburn","year":"1998","journal-title":"Lancet"},{"key":"2025092100262408000_82.4.505.20","first-page":"H1965","article-title":"Endothelin-1 vasoactive responses in lambs with pulmonary hypertension and increased pulmonary flow.","volume":"269","author":"Wong","year":"1995","journal-title":"Am J Physiol"},{"key":"2025092100262408000_82.4.505.21","doi-asserted-by":"publisher","DOI":"10.1378\/chest.114.1_Supplement.39S"},{"key":"2025092100262408000_82.4.505.22","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.21.2169"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/hrt.82.4.505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:26:34Z","timestamp":1758439594000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/hrt.82.4.505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10,1]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[1999,10,1]]},"published-print":{"date-parts":[[1999,10,1]]}},"alternative-id":["10.1136\/hrt.82.4.505"],"URL":"https:\/\/doi.org\/10.1136\/hrt.82.4.505","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"type":"print","value":"1355-6037"},{"type":"electronic","value":"1468-201X"}],"subject":[],"published":{"date-parts":[[1999,10,1]]}}}